The rings are modeled after those that deliver birth control. They carry dapirivine, an experimental AIDS medication. The studies included a placebo ring and were conducted with 4,588 women over five African countries. The women with dapirivine rings were 27 to 31 percent less likely to contract HIV.
The studies found that the rings were more effective with women over 25 due to more consistent use. Consistent application with previous vaginal AIDS medications has been an issue, according to the USA Today piece.
IPM will conduct further studies on the ring and hopes to gain approval for use in South Africa and Uganda.
More articles on infection control:
HPV rates drop despite low immunization rates
The challenge of differentiating infectious, noninfectious ventilator-associated events
Study examines risk of CRE colonization becoming an infection: 3 findings
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.